Enhabit, Inc. Files 8-K with Corporate Updates
Ticker: EHAB · Form: 8-K · Filed: Dec 5, 2024
Sentiment: neutral
Topics: corporate-filing, regulation-fd, financial-statements
Related Tickers: EHAB
TL;DR
Enhabit (EHAB) filed an 8-K confirming HQ address and former name; standard corporate update.
AI Summary
Enhabit, Inc. filed an 8-K on December 5, 2024, to report on Regulation FD disclosures and financial statements. The filing confirms their principal executive offices are located at 6688 N. Central Expressway, Suite 1300, Dallas, Texas, 75206, with a contact phone number of (214) 239-6500. The company was formerly known as Encompass Health Home Health Holdings, Inc., with a name change effective February 18, 2020.
Why It Matters
This filing provides essential corporate information and confirms the company's operational details, which are important for investors and stakeholders to track the company's official status and reporting.
Risk Assessment
Risk Level: low — This is a routine corporate filing with no new material financial information or significant strategic changes disclosed.
Key Players & Entities
- Enhabit, Inc. (company) — Registrant
- December 5, 2024 (date) — Date of Report
- 6688 N. Central Expressway, Suite 1300, Dallas, Texas, 75206 (location) — Principal executive offices address
- (214) 239-6500 (phone_number) — Registrant's telephone number
- Encompass Health Home Health Holdings, Inc. (company) — Former company name
- February 18, 2020 (date) — Date of name change
FAQ
What is the primary purpose of this Form 8-K filing?
The primary purpose of this Form 8-K filing is to report on Regulation FD disclosures and to provide financial statements and exhibits.
What is Enhabit, Inc.'s principal executive office address?
Enhabit, Inc.'s principal executive office is located at 6688 N. Central Expressway, Suite 1300, Dallas, Texas, 75206.
What is the telephone number for Enhabit, Inc.?
The telephone number for Enhabit, Inc. is (214) 239-6500.
What was Enhabit, Inc.'s former company name?
Enhabit, Inc.'s former company name was Encompass Health Home Health Holdings, Inc.
When did the name change from Encompass Health Home Health Holdings, Inc. to Enhabit, Inc. occur?
The name change occurred on February 18, 2020.
Filing Stats: 634 words · 3 min read · ~2 pages · Grade level 10.8 · Accepted 2024-12-05 08:10:25
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share EHAB New York Stock Exchange
Filing Documents
- ehab-20241205.htm (8-K) — 28KB
- exhibit991-202411192024pre.htm (EX-99.1) — 5KB
- exhibit992-supplementali.htm (EX-99.2) — 8KB
- exhibit992-supplementali001.jpg (GRAPHIC) — 45KB
- exhibit992-supplementali002.jpg (GRAPHIC) — 274KB
- exhibit992-supplementali003.jpg (GRAPHIC) — 119KB
- exhibit992-supplementali004.jpg (GRAPHIC) — 115KB
- exhibit992-supplementali005.jpg (GRAPHIC) — 121KB
- 0001803737-24-000203.txt ( ) — 1098KB
- ehab-20241205.xsd (EX-101.SCH) — 2KB
- ehab-20241205_lab.xml (EX-101.LAB) — 22KB
- ehab-20241205_pre.xml (EX-101.PRE) — 13KB
- ehab-20241205_htm.xml (XML) — 3KB
01. Regulation FD Disclosure.*
Item 7.01. Regulation FD Disclosure.* Enhabit, Inc. (the "Company") and UnitedHealthcare ("UHC") recently reached a new multi-year agreement that will allow UHC's members continued access to Enhabit's high-quality home health services. The new agreement terms go into effect January 1, 2025. As previously announced, the Company will be participating in the BofA Securities 2024 Home Care Conference on December 10, 2024, at 9:00 a.m. EST. The Company's President and Chief Executive Officer, Barbara Jacobsmeyer, incoming Chief Financial Officer, Ryan Solomon, and SVP of Strategic Finance & Treasurer, Jobie Williams, will participate in a fireside chat where they intend to discuss the Company's strategic focus and recent business developments, including an update to anticipated pricing impacts for 2025, among other matters. A copy of the press release announcing how to access the conference and the supplemental information which will be discussed at the conference are attached to this report as Exhibits 99.1 and 99.2, respectively, and each are incorporated herein by reference.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press release dated November 19, 2024 (furnished herewith).* 99.2 Supplemental Information dated December 10, 2024 (furnished herewith).* 104 Cover Page Interactive Data File - the cover page iXBRL tags are embedded within the Inline XBRL document * The information in Item 7.01, including Exhibit 99.1, is being "furnished" and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section and shall not be incorporated into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, unless specifically identified as being incorporated therein by reference.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. ENHABIT, INC. By: /s/ Dylan C. Black Name: Dylan C. Black Title: General Counsel Dated: December 5, 2024